476 related articles for article (PubMed ID: 34298601)
1. Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits.
Spiesschaert B; Angerer K; Park J; Wollmann G
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298601
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.
Gujar S; Pol JG; Kim Y; Lee PW; Kroemer G
Trends Immunol; 2018 Mar; 39(3):209-221. PubMed ID: 29275092
[TBL] [Abstract][Full Text] [Related]
3. Immune System, Friend or Foe of Oncolytic Virotherapy?
Filley AC; Dey M
Front Oncol; 2017; 7():106. PubMed ID: 28589085
[TBL] [Abstract][Full Text] [Related]
4. Arming oncolytic viruses to leverage antitumor immunity.
de Gruijl TD; Janssen AB; van Beusechem VW
Expert Opin Biol Ther; 2015 Jul; 15(7):959-71. PubMed ID: 25959450
[TBL] [Abstract][Full Text] [Related]
5. Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
Marchini A; Scott EM; Rommelaere J
Viruses; 2016 Jan; 8(1):. PubMed ID: 26751469
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic viruses as immunotherapy: progress and remaining challenges.
Aurelian L
Onco Targets Ther; 2016; 9():2627-37. PubMed ID: 27226725
[TBL] [Abstract][Full Text] [Related]
7. Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Selman M; Rousso C; Bergeron A; Son HH; Krishnan R; El-Sayes NA; Varette O; Chen A; Le Boeuf F; Tzelepis F; Bell JC; Crans DC; Diallo JS
Mol Ther; 2018 Jan; 26(1):56-69. PubMed ID: 29175158
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors.
Yoon AR; Rivera-Cruz C; Gimble JM; Yun CO; Figueiredo ML
Mol Ther Oncolytics; 2022 Jun; 25():78-97. PubMed ID: 35434272
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Viruses on Drugs: Achieving Higher Therapeutic Efficacy.
Phan M; Watson MF; Alain T; Diallo JS
ACS Infect Dis; 2018 Oct; 4(10):1448-1467. PubMed ID: 30152676
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
Russell L; Peng KW; Russell SJ; Diaz RM
BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623
[TBL] [Abstract][Full Text] [Related]
11. Design and application of oncolytic viruses for cancer immunotherapy.
Ylösmäki E; Cerullo V
Curr Opin Biotechnol; 2020 Oct; 65():25-36. PubMed ID: 31874424
[TBL] [Abstract][Full Text] [Related]
12. Genetic modification of oncolytic viruses to enhance antitumor immunity.
Davola ME; Vito A; Wei J; El-Sayes N; Workenhe S; Mossman KL
Methods Enzymol; 2020; 635():231-250. PubMed ID: 32122548
[TBL] [Abstract][Full Text] [Related]
13. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
Wei D; Xu J; Liu XY; Chen ZN; Bian H
Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
Jhawar SR; Thandoni A; Bommareddy PK; Hassan S; Kohlhapp FJ; Goyal S; Schenkel JM; Silk AW; Zloza A
Front Oncol; 2017; 7():202. PubMed ID: 28955655
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy.
Nguyen HM; Guz-Montgomery K; Saha D
Cells; 2020 Feb; 9(2):. PubMed ID: 32050597
[TBL] [Abstract][Full Text] [Related]
16. Targeting Autophagy for Oncolytic Immunotherapy.
Hu L; Jiang K; Ding C; Meng S
Biomedicines; 2017 Jan; 5(1):. PubMed ID: 28536348
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy.
Kim Y; Clements DR; Sterea AM; Jang HW; Gujar SA; Lee PW
Viruses; 2015 Dec; 7(12):6506-25. PubMed ID: 26690204
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Viruses: Therapeutics With an Identity Crisis.
Breitbach CJ; Lichty BD; Bell JC
EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy.
Zhang Y; Li Y; Chen K; Qian L; Wang P
Cancer Cell Int; 2021 May; 21(1):262. PubMed ID: 33985527
[TBL] [Abstract][Full Text] [Related]
20. NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.
Struzik J; Szulc-Dąbrowska L
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30413032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
